Latest news
Loading news…
Catalent Pharma Solutions
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Bridgewater, New Jersey, United States Founded 2007 10001+ employees For Profit
Catalent provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies.
Catalent Pharma Solutions on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Catalent Pharma Solutions was acquired by Novo Holdings in 2024 for $16.5B.
Total Funding
$1.14B
Funding Rounds
2
Last Funding
Acquisitions
12
Monthly Visits
Contacts
0
Ticker
CTLT
NYSE - New York Stock Exchange
About Catalent Pharma Solutions
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- CTLT
- Exchange
- NYSE - New York Stock Exchange
- IPO date
- Aug 1, 2014
- Raised at IPO
- $871.25M
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 38
- Mobile apps
- 2
- Active products
- 43
- IT spend
- $95.08M
Company Info
- Founded
- 2007
- Employees
- 10001+
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- Sub-organizations
- 2
- News articles
- 219
- Events
- 1
- HQ
- Bridgewater, New Jersey, United States
- Region
- East Coast, Northeastern US
- Exit date
- Aug 1, 2014
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 3.6
- Trend (30d)
- 5.7
- Trend (90d)
- 5.8
- Last leadership hire
- Feb 20, 2025
- Last layoff mention
- Mar 21, 2024
Catalent Pharma Solutions Funding Rounds
2 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–2 of 2Show
Page 1 / 1
Catalent Pharma Solutions Acquisitions
12 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Metrics Contract Services | $475M | 2022-08-09 | Catalent Pharma Solutions | Health CareManufacturingPharmaceutical | United States |
| Bettera Brands | $1B | 2021-08-29 | Catalent Pharma Solutions | Product Design | United States |
| Delphi Genetics | — | 2021-02-23 | Catalent Pharma Solutions | BiotechnologyPharmaceuticalTherapeutics | Belgium |
| Skeletal Cell Therapy Support | $14.04M | 2020-10-29 | Catalent Pharma Solutions | BiotechnologyManufacturingTherapeutics | Belgium |
| MaSTherCell | $315M | 2020-02-03 | Catalent Pharma Solutions | ManufacturingTherapeutics | Belgium |
1–5 of 12Show
Page 1 / 3
Catalent Pharma Solutions Key People
Executive Chair
Member of the Board of Directors
Member of the Board of Directors
Research Fellow
President, Softgel Technologies
President, Advanced Delivery Technologies (ADT)
Principal Scientist, R&D
Senior Vice President & General Counsel
Senior Manager & Event Marketing
Director, Biophysical Characterization and Analysis
Scientist
Member of the Board of Directors
VP, Business Development Cell & Gene Therapy Europe
Manager
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Catalent Pharma Solutions
Loading news…
FAQs about Catalent Pharma Solutions
People who checked this page also checked these
Sectors Catalent Pharma Solutions invests & acquires in
Browse the full Acquirezy directory.